drugset / Trial / NCT05157698
Pharmacological and Behavioral Treatment After Bariatric Surgery
Phase 3
Active not recruiting
84 enrolled
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will compare the effectiveness of behavioral and pharmacologic treatment, alone and combined, for improvements in weight loss, cardiovascular risk factors, and psychosocial functioning following metabolic and bariatric surgery.
Timeline
- Start
- 2022-01-13
- Primary completion
- 2027-01-12
- Completion
- 2028-01-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | — | Oral |
| Subject | Naltrexone | Small molecule | — | Oral |